Back to Search Start Over

Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome.

Authors :
Danlos, François-Xavier
Rossi, Giovanni Maria
Blockmans, Daniel
Emmi, Giacomo
Kronbichler, Andreas
Durupt, Stéphane
Maynard, Claire
Luca, Luminita
Garrouste, Cyril
Lioger, Bertrand
Mourot-Cottet, Rachel
Dhote, Robin
Arlet, Jean-Benoit
Hanslik, Thomas
Rouvier, Philippe
Ebbo, Mikael
Puéchal, Xavier
Nochy, Dominique
Carlotti, Agnès
Mouthon, Luc
Source :
Autoimmunity Reviews. Oct2017, Vol. 16 Issue 10, p1036-1043. 8p.
Publication Year :
2017

Abstract

Objective Atypical manifestations have been described in patients with ANCA-associated vasculitides (AAV), such as pachymeningitis, orbital mass or chronic periaortitis. Because these manifestations have been associated to the spectrum of IgG4-related disease (IgG4-RD), we hypothesized that both diseases could overlap. Methods We conducted a European retrospective multicenter observational study including patients fulfilling ACR and Chapel Hill criteria for AAV and IgG4-RD Comprehensive Diagnostic Criteria. Results Eighteen patients were included (median age 55.5 years, 13 men). AAV and IgG4-RD were diagnosed concomitantly in 13/18 (72%) patients; AAV preceded IgG4-RD in 3/18 (17%) while IgG4-RD preceded AAV in 2/18 (11%). AAV diagnoses included granulomatosis with polyangiitis in 14 (78%), microscopic polyangiitis in 3 (17%), and eosinophilic granulomatosis with polyangiitis in one case. IgG4-RD diagnosis included definite IgG4-RD in 5 (28%) cases, probable IgG4-RD in 5 (28%) and possible IgG4-RD in 8 (44%). IgG4-RD manifestations were chronic periaortitis in 9/18 (50%) patients, orbital mass and tubulointerstitial nephritis in 4 (22%) cases, prevertebral fibrosis in 3 (17%), pachymeningitis and autoimmune pancreatitis in 2 (11%) cases. Patients required median number of 2 (range 0–4) lines of immunosuppressants in combination with glucocorticoids. During the follow-up (median 49,8 months, range 17,25–108 months), AAV manifestations relapsed in 10/18 (56%) cases and IgG4-RD lesions in 5/18 (28%). When used, mainly for relapses, rituximab showed response in all cases. Conclusion AAV and IgG4-RD may overlap. Clinicians should consider that atypical manifestations during AAV could be related to IgG4-RD rather than to refractory granulomatous or vasculitic lesions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15689972
Volume :
16
Issue :
10
Database :
Academic Search Index
Journal :
Autoimmunity Reviews
Publication Type :
Academic Journal
Accession number :
125235455
Full Text :
https://doi.org/10.1016/j.autrev.2017.07.020